Article
Rapid clonal selection within early hematopoietic cell compartments presages outcome to ivosidenib combination therapy
2024-12-31
Abstract excerpt
Acquired resistance to targeted non-intensive therapies is common in myeloid malignancies. Yet, key questions remain as to how rapidly resistant clones are selected by treatment and in which hematopoietic cell compartments clonal selection occurs. To address this gap, we studied clonal responses to ivosidenib + venetoclax +/- azacitidine combination therapy in 8 patients with IDH1-mutant myeloid malignancy. Whilst...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d8ef2c93-c7ef-5315-a832-ccf1e0045dfe
- DOI
- 10.1101/2024.12.30.630700
